BRO vs PTCT · P/E 30, rev $4.80B vs rev $806.8M
Brown & Brown Inc (BRO) versus PTC Therapeutics Inc (PTCT) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported PTCT revenue for 2024-12-31 was $806.8M. Net income was -$363.3M. Revenue was down 14.0% from 2023-12-31 to 2024-12-31. PTCT currently screens at market cap $6.51B.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. PTCT currently screens at market cap $6.51B.
Not investment advice. Open the BRO and PTCT stock pages for the full models.
Not investment advice.